News Quantified

ETON – eton pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN® [Yahoo! Finance]

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules [Yahoo! Finance]

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

15.6%

BEAT

-13.7%

MISS

Form 8-K Eton Pharmaceuticals, For: Mar 14

Form 8-K/A Eton Pharmaceuticals, For: Dec 19

Form 8-K Eton Pharmaceuticals, For: Mar 03

Form SCHEDULE 13G/A Eton Pharmaceuticals, Filed by: EcoR1 Capital, LLC

Form 8-K Eton Pharmaceuticals, For: Feb 07

Top News Gainers

3/27 Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle 34.2%

10/22 Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection 18.4%

4/8 Form D Eton Pharmaceuticals, 11.0%

3/25 Eton Pharmaceuticals Inc (NASDAQ: ETON) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 9.2%

3/12 Eton Pharmaceuticals Inc (NASDAQ: ETON) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 8.9%

1/28 Eton Pharmaceuticals Inc (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $23.00 price target on the stock, up previously from $21.00. 8.0%

9/20 Eton Pharmaceuticals Inc (NASDAQ: ETON) is now covered by analysts at B. Riley. They set a "buy" rating and a $13.50 price target on the stock. 7.0%

3/16 Form 4 Eton Pharmaceuticals, For: Mar 12 Filed by: BRYNJELSEN SEAN 6.9%

4/6 Form 3 Eton Pharmaceuticals, For: Mar 26 Filed by: Opaleye Management Inc. 5.5%

11/13 Eton Pharmaceuticals Announces $10 Million Debt Facility with SWK Holdings 4.5%

Top News Decliners

3/31 Eton Pharmaceuticals Inc (NASDAQ: ETON) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.50 price target on the stock. -16.0%

3/5 Eton Pharmaceuticals, Inc. (ETON) CEO Sean Brynjelsen on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -14.9%

3/17 Eton Pharmaceuticals Reports Positive Study Results for ET-101 (Topiramate Oral Solution) -14.8%

7/12 Eton Pharmaceuticals Provides Update on EM-100 Program -11.1%

3/18 Form 8-K Eton Pharmaceuticals, For: Mar 17 -10.4%

10/22 Form 8-K Eton Pharmaceuticals, For: Oct 22 -8.3%

3/30 Form 8-K Eton Pharmaceuticals, For: Mar 26 -8.3%

2/19 Eton Pharmaceuticals Provides Update on ET-105 Program -7.0%

10/23 Eton Pharmaceuticals Inc (NASDAQ: ETON) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -5.6%

8/5 Eton Pharmaceuticals Inc (NASDAQ: ETON) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock. -5.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day